Hikma FDA Monday, February 22, 1993 0.00 Neutral

FDA Approves LEUCOVORIN CALCIUM — Hikma Pharmaceuticals USA Inc.

Hikma Pharmaceuticals USA Inc. secured the approval of a new generic version of LEUCOVORIN CALCIUM, an essential drug indicated for rescue following methotrexate toxicities, potentially expanding its portfolio within the high-volume oncology and inflammation therapeutics market.

View original filing at SEC.gov →

AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.

Get real-time financial news in your trading bot or app

GET FREE KEY — 10,000 calls/day